CClinicalTrials.gg
CompletedNCT05255380EMMAUpdated May 4, 2025

Examine the Effects of Mindfulness in Woman With a History of Child Adversity

An interventional study of Mindfulness and compassion-based practices; approximately 5-10 minutes two times/day and Mindful awareness and reporting of current thoughts and feelings, 2 times/day in Stress, Psychological Stress and Child Maltreatment, sponsored by University of California, San Francisco. Completed at 1 site in United States. Open to female participants aged 30 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-05-04.

Sponsored by University of California, San Francisco · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
72
Allocation
Randomized
Ages
30 Years to 50 Years
Sex
Female
01

Study summary

The aim of this pilot Randomized Controlled Trial (RCT) is to test whether brief mindfulness-based practices will improve well-being and health in women (age 30-50) with a history of early life adversity. Following a baseline visit (remotely via Zoom), participants are randomized (50% probability) to either a Mindful Activity group or a Mindful Awareness group. In the Mindful Activity group, participants will complete brief (approximately 5-10 min) audio-guided mindfulness practices twice a day (morning and evening) for 8 weeks using the study app. This is followed by a brief survey about their current thoughts and feelings. In the Mindful Awareness group, participants are asked to be mindful (pay attention) to their thoughts and feelings twice a day (morning and evening) for 8 weeks using the study app. After the 8-week intervention period, all participants complete a follow-up visit (remotely). Primary goals of the pilot RCT are to test acceptability, feasibility, and adherence.

Read the detailed description

The pilot Randomized Controlled Trial (RCT) randomly assigns midlife women (age 30-50) with a history of early life adversity to either a Mindful Activity group or a Mindful Awareness group to primarily test acceptability, feasibility, and adherence. Randomization will occur by chance at the end of the baseline visit.

Participants randomized to the Mindful Activity group will receive 8 weeks of ecological momentary assessment and intervention sessions via the study app. Mindfulness-based interventions consist of mindfulness and compassion-based practices. For example, practices focus on the breath/body (e.g., 3-minute breathing space; compassionate body scan; five senses mediation), on increasing participants' inner resources (e.g., imaging a safe person or safe place), on reducing negative affect (e.g., self-compassionate and acceptance-based practices), or on increasing positive emotions (e.g., gratitude practice; metta practices). All interventions are audio-guided and approximately 5-10 minutes. Participants complete two mindfulness interventions/day (one in the morning; one in the evening). After completing a mindfulness-based intervention, participants will complete ecological momentary assessments of their current psychological stress states (e.g., stress appraisals, affect, perseverative cognitions, self-criticism, social connection) via the study app.

Participants randomized to the Mindful Awareness group are instructed to be mindful (pay attention) to their current thoughts and feelings and complete ecological momentary assessments of their current psychological stress states (e.g., stress appraisals, affect, perseverative cognitions, self-criticism, social connection) twice/day (morning and evening) for 8 weeks via the study app.

A trained research assistant will monitor participant adherence and address potential difficulties. All participants will complete assessments at baseline (pre-intervention) and post-intervention (after the 8-week intervention). Weekly measures of depressive symptoms are also obtained. The investigators plan to consent about 100 participants with the goal of having 70 eligible participants enrolled in the study (about 35 in each group).

02

Conditions studied

  • Stress
  • Psychological Stress
  • Child Maltreatment
  • Depressive Symptoms
  • Signs and Symptoms

Keywords

  • Mindfulness
  • Adverse childhood experiences
  • Stress
  • Depressive symptoms
03

In context

Depression

8,057 studies on the registry are indexed under Depression; 1,641 are open to participants now.

This study's enrollment of 72 is below the median of 84 across 6,720 interventional studies indexed under Depression.

Browse Depression studies →

Lead sponsor

University of California, San Francisco is the lead sponsor of 2,132 studies on the registry; 375 are open to participants now.

Of its 262 completed or terminated interventional studies of FDA-regulated products, 196 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  1. female sex and gender identity (to control for sex and gender differences in stress responses and health outcomes)
  2. age 30-50 (to examine intervention effects on health outcomes in midlife)
  3. ≥2 Adverse Childhood Experiences (to ensure exposure to early life adversity)
  4. mild depressive symptoms (to allow for outcome improvements: PHQ-9 ≥ 5)
  5. having a smartphone (to access app-based assessments/interventions)

Exclusion criteria

Exclusion Criteria:

  1. Non-English speaker or unable to provide informed consent
  2. Current regular mindfulness practice (exclude if >20 min/week)
  3. Major psychiatric condition, including psychosis/schizophrenia, bipolar disorder, post-traumatic stress disorder, eating disorders, alcohol/substance use, major depression (PHQ-9 ≥ 15), and self-harm or suicidal ideation
  4. Major medical conditions, including no history of coronary heart disease, diabetes, severe asthma or lung disease, autoimmune disorders, infectious disease, epilepsy, brain injury, endocrine disorders, diagnosis of cancer or chemotherapy or radiation in the past 10 years
  5. Free from medications known to affect the immune and endocrine systems with the exception of antidepressant medication and oral contraceptives
  6. Psychotherapy treatment permitted if stable (≥3 months)
  7. Current smoking and nicotine use
  8. Currently pregnant
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
72 participants (actual)

Study arms

  • Experimental
    Mindful Activity group

    Participants complete mindfulness and compassion-based practices via the study app.

    Behavioral: Mindfulness and compassion-based practices; approximately 5-10 minutes two times/day

  • Sham comparator
    Mindful Awareness group

    Participants monitor and report their thoughts and feelings via the study app.

    Behavioral: Mindful awareness and reporting of current thoughts and feelings, 2 times/day

Interventions

  • BehavioralMindfulness and compassion-based practices; approximately 5-10 minutes two times/day

    The app-based (audio-guided) interventions consist of mindfulness and compassion-based practices that are selected to maximize their effect on stress targets. Interventions include, for example, practices that focus on the breath/body (e.g., 3-minute breathing space; compassionate body scan; five senses mediation), on increasing participants' inner resources (e.g., imaging a safe person or safe place), on reducing negative affect (e.g., self-compassion and acceptance-based practices), or on increasing positive emotions (e.g., gratitude practice; metta practices).

  • BehavioralMindful awareness and reporting of current thoughts and feelings, 2 times/day

    Participants are instructed to be mindful (pay attention) to their current thoughts and feelings and complete ecological momentary assessments of their current psychological stress states (e.g., stress appraisals, affect, perseverative cognitions, self-criticism, social connection)

06

What researchers measure

Primary outcomes

  1. Acceptability of the intervention will be measured with an adapted version of the Treatment Acceptability Questionnaire (TAQ).

    The Treatment Acceptability Questionnaire (TAQ) is a six-item scale assessing whether participants view their assigned intervention as acceptable, ethical, and effective. Items are rated on a 7-point Likert scale (e.g., 1 "very unacceptable" to 7 "very acceptable), with a possible score range from 6 to 42. Higher scores indicate better treatment acceptability and positive perceptions of the treatment. A total mean score of at least 24 will indicate sufficient acceptability of the intervention.

    Time frame: Assessed at post-intervention, approximately 8 weeks from baseline

  2. Feasibility, as indicated by numbers of participants screened (completed web-based screener and phone screener), eligible based on web-based screener and phone screener, consented, randomized to treatment, and retained at follow-up.

    Feasibility outcomes will include: \>70% of eligible participants (passed web-based and phone screener) will be consented, \>70% of consented participants will pass further baseline screening procedures and will be randomized to treatment, \>70% of participants who are randomized to treatment will be retained at follow-up. Reasons for ineligibility and drop out will also be assessed.

    Time frame: Anticipated study period of 12 months

  3. Adherence, as measured by the percentage of assigned and completed intervention group practices.

    Completion of at least 50% of assigned intervention group practices (Ecological Momentary Assessments for Mindful Awareness group; mindfulness practices for Mindful Activity group) is considered acceptable.

    Time frame: Baseline to follow-up, an anticipated 8 weeks

Secondary outcomes

  1. Change in depressive symptoms, as measured by the total score on the 9-item Patient Health Questionnaire (PHQ-9).

    The 9-item Patient Health Questionnaire (PHQ-9) has a total score scale range of 0 to 27, with higher values indicating more depressive symptoms.

    Time frame: Baseline to post-intervention, an anticipated 8 weeks

07

Study locations

1 site
  • University of California, San Francisco
    San Francisco, California 94118, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 4, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05255380
Lead sponsor
University of California, San Francisco
Collaborators
National Institute on Aging (NIA)
Responsible party
Sponsor
First posted
Feb 24, 2022
Start date
Jun 3, 2022
Primary completion
Apr 19, 2024
Completion
Apr 19, 2024
Last update
May 4, 2025

Study contacts

Stefanie E Mayer, PhD
principal investigator · University of California, San Francisco

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion